Disruptability [+]

Species Disruptability Reference Submitter
P. berghei ANKA
Possible
RMgm-4413 Imported from RMgmDB
P. berghei ANKA
Possible
PlasmoGEM (Barseq) PlasmoGEM
P. falciparum 3D7
Possible
USF piggyBac screen (Insert. mut.) USF PiggyBac Screen

Mutant phenotypes [+]

Species Stage Phenotype Reference Submitter
P. berghei ANKA Asexual
No difference
RMgm-4413 Imported from RMgmDB
P. berghei ANKA Asexual
No difference
PlasmoGEM (Barseq) PlasmoGEM
P. berghei ANKA Gametocyte
No difference
RMgm-4413 Imported from RMgmDB
P. berghei ANKA Ookinete
No difference
RMgm-4413 Imported from RMgmDB
P. berghei ANKA Oocyst
No difference
RMgm-4413 Imported from RMgmDB
P. berghei ANKA Sporozoite
No difference
RMgm-4413 Imported from RMgmDB
P. berghei ANKA Liver
Difference from wild-type
RMgm-4413
Reduced growth of liver stages (At 24 hpi, HCS1 parasites were 3 m2 smaller, at 48h 53 m2, at 56h 73 m2 smaller than WT controls). Reduced merozoite/merosome formation.A delay of 2.1 days of the prepatent period after infecting mice with 5.000 sporozoites. Reduced infectivity of merozoites/merosomes produces as measured by blood infections in mice infected with merozoites/merosomes
Imported from RMgmDB

More information

PlasmoDB PBANKA_0511000
GeneDB PBANKA_0511000
Malaria Metabolic Pathways Localisation images
Pathways mapped to
Previous ID(s) PB000416.00.0, PBANKA_051100
Orthologs PCHAS_0511100 , PF3D7_1026900 , PKNH_0611300 , PVP01_0612000 , PVX_111375 , PY17X_0512100
Google Scholar Search for all mentions of this gene